Bleichroeder LP Magenta Therapeutics, Inc. Transaction History

Bleichroeder LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.36 - $1.59 $49,596 - $219,052	-137,769 Reduced 28.44%	346,631 $138,000
Q4 2021 Feb 10, 2022	BUY	$4.43 - $8.33 $221,500 - $416,500	50,000 Added 11.51%	484,400 $2.15 Million
Q4 2020 Feb 10, 2021	BUY	$6.1 - $7.94 $503,402 - $655,248	82,525 Added 23.45%	434,400 $3.41 Million
Q2 2020 Aug 12, 2020	BUY	$6.18 - $10.76 $2.16 Million - $3.77 Million	350,293 Added 22142.41%	351,875 $2.64 Million
Q1 2020 May 14, 2020	SELL	$6.03 - $15.24 $1.51 Million - $3.81 Million	-250,293 Reduced 99.37%	1,582 $9,000
Q1 2020 May 14, 2020	BUY	$6.03 - $15.24 $1.52 Million - $3.84 Million	251,875 New	251,875 $1.58 Million

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Bleichroeder LP, based on Form 13F filings with the SEC.

Stay updated on Bleichroeder LP with notifications on news.